HOVR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HOVR is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive technical signals and a bullish analyst initiation, but the absence of a proprietary buy signal, insider selling, no clear financial snapshot, and the recent capital raise make the risk-reward less compelling for an immediate long-term purchase. Given the user's impatience and lack of interest in waiting for an ideal entry, I would still not recommend buying now; hold off until the company shows clearer financial progress and stronger confirmation from trading signals.
Price is in pre-market at 2.40, down 0.83%, while the broader market is also weak (-1.0% on the S&P 500). Technically, HOVR is in an uptrend based on moving averages with SMA_5 > SMA_20 > SMA_200, which is a bullish structure. MACD histogram is positive at 0.0106 but contracting, suggesting bullish momentum is fading. RSI_6 at 56.385 is neutral, so the stock is not overbought. The pivot at 2.449 sits just above the current pre-market price, with near resistance at 2.73 and support at 2.169. Near-term pattern data suggests mixed performance, with small downside next day and only modest short-term upside, making the current entry less attractive for an impatient buyer.
JonesResearch initiated coverage with a Buy rating and an $18 price target, which is a strong bullish sentiment catalyst. The company also raised approximately $20 million in a direct offering to fund the Cavorite X7 program, which supports ongoing development and can help advance the business if execution improves.
Insiders are selling, and the amount sold increased 256.86% over the last month, which is a notable negative signal. Hedge funds are neutral with no significant accumulation trend. The recent direct offering adds dilution pressure. There is no meaningful congress trading data, and no recent politician buying activity was provided to support the stock.
No usable latest-quarter financial snapshot was provided, so there is no confirmed quarter-by-quarter revenue, earnings, or margin trend to assess. Based on the available data, there is not enough financial evidence to support a confident long-term buy decision at this time.
Analyst sentiment is bullish on the surface: JonesResearch initiated coverage on 2026-02-23 with a Buy rating and an $18 price target, far above the current price. This is a strong upside projection and a clear pro-bull view. However, the broader Wall Street picture is incomplete, and the bullish initiation is not yet reinforced by strong proprietary signals or supportive insider behavior.
